Sunpeaks Ventures, Inc. (SNPK.OB, SNPK.PK) and its wholly owned subsidiary Healthcare Distribution Specialists, LLC or "HDS" announce that HDS has signed a Letter of Intent with PharmaLife for placement of Clotamin with leading pharmacies in the Russian Federation.
The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma.
by RTT Staff Writer
For comments and feedback: editorial@rttnews.com
Business News